eifeler Holding GmbH & Co. KG, a leading global provider of medical coatings, acquired a minority interest in Medicoat AG on October 25, 2017.
With this investment, eifeler not only deepens its strong know-how in the field of medical coating technology, but also extends its expertise to the development and production of complete coating systems and consumables for thermal spraying.

Medicoat AG and eifeler group are looking forward to the future bundling forces in the field of medical coating technology. In the picture from left Philipp Gruner (CEO Medicoat AG), Heiko Gruner (founder and president Medicoat AG), Hans W. Eifeler (founder and shareholder eifeler Holding), Thomas Michel (member of the board Medicoat AG)

eifeler group has been active in the growing market of high-tech coatings for 30 years and ranks among the leading companies in the coating market worldwide. Following the divestiture of its tool coating division in 2013, the company today focuses on developing and applying innovative coating solutions to a variety of industries, in particular medical technology, with highly qualified engineers, physicists and chemists in its own research and development laboratories and coating centers.

Founded in 1989, Medicoat AG, based in Switzerland, is an innovative company in the field of thermal spraying technology with a focus on plasma spraying. Medicoat offers complete coating systems including wettable powders and develops spray coatings for medical and other industrial applications. Medicoat specializes in atmospheric and vacuum plasma spraying (APS, VPS) for coatings of medical implants with very pure titanium and hydroxyapatite in optimized crystallinity. In addition, the company serves a variety of international OEMs in the orthopedic industry as a contract manufacturer with the coating of implants. In addition to its head office in Mägenwil (Switzerland), Medicoat operates sites in Wohlen (Switzerland), Hunzenschwil (Switzerland) and Etupes (France).